Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Psychiatr Genet. 2009 Dec;19(6):281–291. doi: 10.1097/YPG.0b013e32832a506e

Table 2.

Mixed model of the response to citalopram for HTR1BSNPs and haplotypes.

SNP Genotypes N (frequency) EMMa s.e.m. Pvalue
rs11568817 b TT 49 (0.32) 8.51 0.463 0.459
TG 70 (0.46) 8.41 0.393
GG 32 (0.21) 9.24 0.566
rs130058b AA 77 (0.52) 8.91 0.368 0.045
AT 59 (0.40) 8.09 0.422
TT 11 (0.08) 10.52 0.938
rs6296b GG 82 (0.54) 9.39 0.352 0.01
GC 60 (0.39) 7.78 0.397
CC 11 (0.07) 8.46 0.904
rs6297c AA 1296 (0.871) 10.83 0.103 0.679
AG 183 (0.123) 10.59 0.259
GG 9 (0.006) 10.94 1.151
rs6298c CC 795 (0.54) 9.58 0.148 0.022
CT 558 (0.38) 9.23 0.177
TT 125 (0.08) 10.32 0.372
rs1213366c AA 463 (0.31) 11.00 0.165 0.191
AG 726 (0.48) 10.64 0.133
GG 312 (0.21) 10.88 0.200
Haplotypesb
Low No haplotype 4 104 (68.9) 8.59 0.319 0.034
Medium 1 haplotype 4 43 (28.5) 8.29 0.485
High 2 haplotype 4 4 (2.6) 12.48 1.520
a

Estimated QIDS-C marginal means over time

b

SNPs genotyped in exploratory sample. Haplotype 4 from table 4

c

SNPs genotyped in extended sample